HDFC Pharma and Healthcare Fund vs HDFCG15ETF
Portfolio Overlap Analysis · HDFC vs HDFC
12.2%
Low Overlap
2 common stocks · Rank #17842 of 28,292 pairs
Common Holdings (2)
| Stock | Wt% in HDFC Pharma and Healthcare | Wt% in HDFCG15ETF | Overlap |
|---|---|---|---|
Sun Pharmaceutical Industries Ltd. Pharmaceuticals & Biotechnology | 8.44% | 9.81% | 8.44% |
Divis Laboratories Ltd. Pharmaceuticals & Biotechnology | 3.74% | 8.38% | 3.74% |
Unique to HDFC Pharma and Healthcare
- Glenmark Pharmaceuticals Ltd.6.62%
- Lupin Ltd.6.44%
- Max Healthcare Institute Limited6.36%
- Alkem Laboratories Ltd.6.21%
- Aster DM Healthcare Limited5.42%
- Ipca Laboratories Ltd.4.80%
- Anthem Biosciences Limited4.46%
- Fortis Healthcare Limited4.02%
Unique to HDFCG15ETF
- Mahindra & Mahindra Ltd.13.91%
- Infosys Limited12.84%
- Tata Consultancy Services Ltd.12.35%
- Hindustan Unilever Ltd.9.52%
- Maruti Suzuki India Limited8.94%
- Titan Company Ltd.8.19%
- TVS Motor Company Ltd.4.17%
- Apollo Hospitals Enterprise Ltd.3.69%
Sector Overlap Breakdown
Pharmaceuticals & Biotechnology12.2% (2)
Analysis
AI-generated comparative analysis coming soon.
More comparisons for HDFC Pharma and Healthcare
- vs SBI Healthcare Opportunities54.8% · 16 stocks
- vs HEALETF46.5% · 10 stocks
- vs NH42.6% · 10 stocks
- vs NIPPON INDIA PHARMA41.7% · 13 stocks
- vs ICICI Prudential Nifty Pharma 40.0% · 9 stocks
More comparisons for HDFCG15ETF
- vs Nippon India ETF Nifty 50 Shar43.3% · 5 stocks
- vs SBI Nifty Consumption ETF36.0% · 8 stocks
- vs SBI Nifty India Consumption In36.0% · 8 stocks
- vs HDFC Nifty India Consumption I36.0% · 8 stocks
- vs NIPPON INDIA ETF NIFTY INDIA C35.9% · 8 stocks
Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.